A cancer patient, Ken Harries, 61, has become the first person in UK to get a robotically constructed bladder. This procedure is known as a radical cystectomy and neo-bladder and was carried out by carried out by Southmead Hospital consultant urologists Edward Rowe and Anthony Koupparis.
Surgeons at Southmead Hospital in Bristol removed his bladder through five small incisions and replaced it with the bladder which was constructed from Ken's own bowel tissue with the help of a robot called Da Vinci. This robotically created neo-bladder functions almost as a normal bladder does.
Bladder Cancer
Bladder Cancer affects the urinary bladder and can be superficial or deep type and this affects its recurrence rate & prognosis.
Advertisement
Dr. Rowe said, "Traditionally this is a major operation with a large incision but we hope that by using this minimal access route we can decrease the trauma to the patient. This enables them to obtain a faster recovery and return to normal activity."
Source: Medindia
Advertisement
 Probiotics - Support System for the GutProbiotics are live microorganisms that resemble the "good bacteria" in our gut. Science is yet to fully explore the healing potential of probiotics; meanwhile some studies have ruled in their favor. | Advertisement
|
Air Pollution and Cancer Incidence: a Danish Cohort Study
Air pollution is on the increase and so are the associated risks. A recently published study links air pollution near residence and cancer.
Advertisement
Recommended Readings
Latest Cancer News
The new study uncovers the efficacy of fixed-duration combination treatment in patients with high-risk leukemia.
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable